Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Food Chemistry|August 22, 2020
Phytochemical composition and variability in Quercus ilex acorn morphotypes as determined by NIRS and MS-based approachesCristina López-Hidalgo, Macedonia Trigueros, Macarena Menéndez, et al.Current Protocols|April 17, 2026
Multiparametric Characterization of Telomere Length in T Cells by Flow-FISHMacedonia Trigueros, Yacine Kharraz, Hammad Alzayat, et al.Breast (Edinburgh, Scotland)|January 25, 2022
Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: Preclinical and real-life clinical dataAdrià Bernat-Peguera, Macedonia Trigueros, Angélica Ferrando-Díez, et al.International Journal of Molecular Sciences|October 26, 2024
Immunoaging at Early Ages Could Drive a Higher Comorbidity Burden in People with HIV on Antiretroviral Therapy Compared with the Uninfected PopulationCora Loste, Macedonia Trigueros, Francisco Muñoz-López, et al.Journal of Translational Medicine|July 11, 2025
Recurrent waning of anti-SARS-CoV-2 neutralizing antibodies despite multiple antigen encountersEdwards Pradenas, Victor Urrea, Silvia Marfil, et al.Iscience|March 31, 2023
Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralizationEdwards Pradenas, Silvia Marfil, Víctor Urrea, et al.Vaccines|July 30, 2025
Immune Durability and Breakthrough Infections 15 Months After SARS-CoV-2 Boosters in People over 65: The IMMERSION StudyConcepció Violán, Bibiana Quirant-Sánchez, Maria Palau-Antoja, et al.International Journal of Molecular Sciences|November 27, 2024
Assessing the Prognostic Value of Cytoplasmic and Stromal Caveolin-1 in Early Triple-Negative Breast Cancer Undergoing Neoadjuvant ChemotherapyIris Teruel, Eva Castellà, Sabela Recalde, et al.Life Science Alliance|August 12, 2022
Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional studyEugenia Abella, Macedonia Trigueros, Edwards Pradenas, et al.Age and Ageing|May 20, 2022
Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilitiesMacedonia Trigueros, Edwards Pradenas, Dolors Palacín, et al.Pageof 1